Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Open-Label, Blinded Endpoint Evaluation, Active Controlled Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing Elective Primary Unilateral Total Knee Arthroplasty
Conditions
Interventions
SRSD107
enoxaparin
Locations
1
Czechia
Hospital Nové Město na Moravě
Nové Město na Moravě, Czechia
Start Date
September 16, 2025
Primary Completion Date
June 30, 2026
Completion Date
October 31, 2026
Last Updated
January 15, 2026
NCT06189313
NCT07015905
NCT03728166
NCT06393868
NCT07310693
NCT07288632
Lead Sponsor
Sirius Therapeutics Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions